Evaluation of the peri-strut low intensity area following sirolimus- and paclitaxel-eluting stents implantation: Insights from an optical coherence tomography study in humans

International Journal of Cardiology

Volumn 157, Issue 1, 2012, Pages 38-42

  Otake, Hiromasa ^a,b   Shite, Junya ^a   Ikeno, Fumiaki ^b   Shinke, Toshiro ^a   Teramoto, Tomohiko ^b   Miyoshi, Naoki ^a   Ako, Junya ^b   Honda, Yasuhiro ^b   Fitzgerald, Peter J ^b   Hirata, Ken Ichi ^a  

^a KOBE UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b STANFORD UNIVERSITY   (United States)

Author keywords

Optical coherence tomography; Paclitaxel eluting stents; Peri strut low intensity area; Sirolimus eluting stents

Indexed keywords

FIBRINOGEN; PACLITAXEL; RAPAMYCIN;

AGED; ANGIOCARDIOGRAPHY; ARTERIAL WALL THICKNESS; ARTICLE; CARDIOVASCULAR PARAMETERS; CLINICAL EVALUATION; CONTROLLED STUDY; CORONARY ARTERY DISEASE; DIAGNOSTIC IMAGING; DISEASE ASSOCIATION; DRUG ELUTING STENT; EXTRACELLULAR MATRIX; FEMALE; FOLLOW UP; HUMAN; IMAGE DISPLAY; IN-STENT RESTENOSIS; INTERMETHOD COMPARISON; MAJOR CLINICAL STUDY; MALE; NEOINTIMA; OBSERVATIONAL STUDY; OPTICAL COHERENCE TOMOGRAPHY; OUTCOME ASSESSMENT; PERI STRUT LOW INTENSITY AREA; PRIORITY JOURNAL; PROGNOSIS; RETROSPECTIVE STUDY;

AGED; CORONARY ARTERY DISEASE; DRUG-ELUTING STENTS; FEMALE; FOLLOW-UP STUDIES; HUMANS; MALE; MIDDLE AGED; NEOINTIMA; PACLITAXEL; RETROSPECTIVE STUDIES; SIROLIMUS; TOMOGRAPHY, OPTICAL COHERENCE; TREATMENT OUTCOME;

EID: 84860232517     PISSN: 01675273     EISSN: 18741754     Source Type: Journal    
DOI: 10.1016/j.ijcard.2010.11.006     Document Type: Article

References (22)

1. T. Teramoto, F. Ikeno, and H. Otake Intriguing peri-strut low-intensity area detected by optical coherence tomography after coronary stent deployment Circ J 74 6 2010 1257 1259
2. H.G. Bezerra, M.A. Costa, G. Guagliumi, A.M. Rollins, and D.I. Simon Intracoronary optical coherence tomography: a comprehensive review clinical and research applications JACC Cardiovasc Interv. 2 11 2009 1035 1046
3. R. Mehran, G. Dangas, and A.S. Abizaid Angiographic patterns of in-stent restenosis: classification and implications for long-term outcome Circulation 100 18 1999 1872 1878
4. D. Matsumoto, J. Shite, and T. Shinke Neointimal coverage of sirolimus-eluting stents at 6-month follow-up: evaluated by optical coherence tomography Eur Heart J 28 8 2007 961 967
5. Barlis P, Dimopoulos K, Tanigawa J, et al. Quantitative analysis of intracoronary optical coherence tomography measurements of stent strut apposition and tissue coverage. Int J Cardiol 2010;141(2):151-6.
6. H.M. van Beusekom, F. Saia, and J.D. Zindler Drug-eluting stents show delayed healing: paclitaxel more pronounced than sirolimus Eur Heart J 28 8 2007 974 979
7. Nagai H., Ishibashi-Ueda H., and Fujii K. Histology of highly echolucent regions in optical coherence tomography images from two patients with sirolimus-eluting stent restenosis Catheter Cardiovasc Interv 2009
8. A.V. Finn, F.D. Kolodgie, and J. Harnek Differential response of delayed healing and persistent inflammation at sites of overlapping sirolimus- or paclitaxel-eluting stents Circulation 112 2 2005 270 278
9. A.V. Finn, G. Nakazawa, and M. Joner Vascular responses to drug eluting stents: importance of delayed healing Arterioscler Thromb Vasc Biol 27 7 2007 1500 1510
10. Nakazawa G., Finn A.V., John M.C., Kolodgie F.D., and Virmani R. The significance of preclinical evaluation of sirolimus-, paclitaxel-, and zotarolimus-eluting stents Am J Cardiol 100 8B 2007 36M 44M
11. Wilson G.J., Nakazawa G., and Schwartz R.S. Comparison of inflammatory response after implantation of sirolimus- and paclitaxel-eluting stents in porcine coronary arteries Circulation 120 2 2009 141 149 1-2
12. M. Joner, A.V. Finn, and A. Farb Pathology of drug-eluting stents in humans: delayed healing and late thrombotic risk J Am Coll Cardiol 48 1 2006 193 202
13. I.K. Jang, B.E. Bouma, and D.H. Kang Visualization of coronary atherosclerotic plaques in patients using optical coherence tomography: comparison with intravascular ultrasound J Am Coll Cardiol 39 4 2002 604 609
14. I.K. Jang, G.J. Tearney, and B. MacNeill In vivo characterization of coronary atherosclerotic plaque by use of optical coherence tomography Circulation 111 12 2005 1551 1555
15. G.J. Tearney, H. Yabushita, and S.L. Houser Quantification of macrophage content in atherosclerotic plaques by optical coherence tomography Circulation 107 1 2003 113 119
16. Takano M, Yamamoto M, Murakami D, et al. Optical coherence tomography after new scoring balloon angioplasty for in-stent restenosis and de novo coronary lesions. Int J Cardiol 2010;141(3):e51-3.
17. Gonzalo N, Serruys PW, Barlis P, Ligthart J, Garcia-Garcia HM and Regar E. Multi-modality intra-coronary plaque characterization: a pilot study. Int J Cardiol 2010;138(1):32-9.
18. A. Kastrati, W. Koch, and P.B. Berger Protective role against restenosis from an interleukin-1 receptor antagonist gene polymorphism in patients treated with coronary stenting J Am Coll Cardiol 36 7 2000 2168 2173
19. P. Libby, S.J. Warner, and G.B. Friedman Interleukin 1: a mitogen for human vascular smooth muscle cells that induces the release of growth-inhibitory prostanoids J Clin Invest 81 2 1988 487 498
20. R. Riessen, J.M. Isner, E. Blessing, C. Loushin, S. Nikol, and T.N. Wight Regional differences in the distribution of the proteoglycans biglycan and decorin in the extracellular matrix of atherosclerotic and restenotic human coronary arteries Am J Pathol 144 5 1994 962 974
21. C. Hehrlein, S. Kaiser, R. Riessen, J. Metz, P. Fritz, and W. Kubler External beam radiation after stent implantation increases neointimal hyperplasia by augmenting smooth muscle cell proliferation and extracellular matrix accumulation J Am Coll Cardiol 34 2 1999 561 566
22. L.G. Shewan, and A.J. Coats Ethics in the authorship and publishing of scientific articles Int J Cardiol 144 2 2010 1 2